Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC35D3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | RP11-231C14.4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF484 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TMEM105 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | RFC4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | CEP83 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GAD2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PROSER2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MAGOH | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |